HALEON PLC-ADR (HLN) Fundamental Analysis & Valuation

NYSE:HLN • US4055521003

Current stock price

9.84 USD
-0.17 (-1.7%)
At close:
9.84 USD
0 (0%)
After Hours:

This HLN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. HLN Profitability Analysis

1.1 Basic Checks

  • HLN had positive earnings in the past year.
  • HLN had a positive operating cash flow in the past year.
  • HLN had positive earnings in each of the past 5 years.
  • HLN had a positive operating cash flow in each of the past 5 years.
HLN Yearly Net Income VS EBIT VS OCF VS FCFHLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

1.2 Ratios

  • The Return On Assets of HLN (5.11%) is better than 86.01% of its industry peers.
  • HLN's Return On Equity of 10.15% is amongst the best of the industry. HLN outperforms 84.46% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 7.04%, HLN belongs to the top of the industry, outperforming 84.46% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for HLN is significantly below the industry average of 13.10%.
  • The last Return On Invested Capital (7.04%) for HLN is above the 3 year average (6.87%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.11%
ROE 10.15%
ROIC 7.04%
ROA(3y)4.13%
ROA(5y)3.89%
ROE(3y)8.46%
ROE(5y)7.43%
ROIC(3y)6.87%
ROIC(5y)6.44%
HLN Yearly ROA, ROE, ROICHLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • HLN's Profit Margin of 15.11% is amongst the best of the industry. HLN outperforms 88.60% of its industry peers.
  • In the last couple of years the Profit Margin of HLN has grown nicely.
  • The Operating Margin of HLN (22.78%) is better than 89.64% of its industry peers.
  • In the last couple of years the Operating Margin of HLN has remained more or less at the same level.
  • HLN has a better Gross Margin (65.01%) than 70.98% of its industry peers.
  • HLN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 22.78%
PM (TTM) 15.11%
GM 65.01%
OM growth 3Y0.53%
OM growth 5Y0.46%
PM growth 3Y15.68%
PM growth 5Y5.48%
GM growth 3Y1.63%
GM growth 5Y1.07%
HLN Yearly Profit, Operating, Gross MarginsHLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. HLN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HLN is destroying value.
  • The number of shares outstanding for HLN has been reduced compared to 1 year ago.
  • Compared to 5 years ago, HLN has less shares outstanding
  • HLN has a better debt/assets ratio than last year.
HLN Yearly Shares OutstandingHLN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
HLN Yearly Total Debt VS Total AssetsHLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • HLN has an Altman-Z score of 2.49. This is not the best score and indicates that HLN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.49, HLN is in the better half of the industry, outperforming 62.69% of the companies in the same industry.
  • HLN has a debt to FCF ratio of 3.87. This is a good value and a sign of high solvency as HLN would need 3.87 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.87, HLN belongs to the top of the industry, outperforming 87.56% of the companies in the same industry.
  • A Debt/Equity ratio of 0.47 indicates that HLN is not too dependend on debt financing.
  • HLN's Debt to Equity ratio of 0.47 is on the low side compared to the rest of the industry. HLN is outperformed by 64.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.87
Altman-Z 2.49
ROIC/WACC0.83
WACC8.48%
HLN Yearly LT Debt VS Equity VS FCFHLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • HLN has a Current Ratio of 0.92. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of HLN (0.92) is worse than 89.12% of its industry peers.
  • A Quick Ratio of 0.71 indicates that HLN may have some problems paying its short term obligations.
  • HLN has a worse Quick ratio (0.71) than 88.08% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.71
HLN Yearly Current Assets VS Current LiabilitesHLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. HLN Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.59% over the past year.
  • The Earnings Per Share has been growing by 17.56% on average over the past years. This is quite good.
  • Looking at the last year, HLN shows a decrease in Revenue. The Revenue has decreased by -0.61% in the last year.
  • HLN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.78% yearly.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%280.16%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-0.29%

3.2 Future

  • Based on estimates for the next years, HLN will show a small growth in Earnings Per Share. The EPS will grow by 7.38% on average per year.
  • The Revenue is expected to grow by 3.26% on average over the next years.
EPS Next Y6.33%
EPS Next 2Y8.72%
EPS Next 3Y9.09%
EPS Next 5Y7.38%
Revenue Next Year-1.37%
Revenue Next 2Y0.95%
Revenue Next 3Y2.1%
Revenue Next 5Y3.26%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HLN Yearly Revenue VS EstimatesHLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
HLN Yearly EPS VS EstimatesHLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.1 0.2 0.3 0.4 0.5

More info and screens

Find the best growth stocksShow best growing peers

6

4. HLN Valuation Analysis

4.1 Price/Earnings Ratio

  • HLN is valuated rather expensively with a Price/Earnings ratio of 20.08.
  • Based on the Price/Earnings ratio, HLN is valued cheaper than 82.90% of the companies in the same industry.
  • HLN is valuated rather cheaply when we compare the Price/Earnings ratio to 26.86, which is the current average of the S&P500 Index.
  • HLN is valuated rather expensively with a Price/Forward Earnings ratio of 17.16.
  • HLN's Price/Forward Earnings ratio is rather cheap when compared to the industry. HLN is cheaper than 80.83% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 37.39. HLN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 20.08
Fwd PE 17.16
HLN Price Earnings VS Forward Price EarningsHLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 82.90% of the companies in the same industry are more expensive than HLN, based on the Enterprise Value to EBITDA ratio.
  • 87.56% of the companies in the same industry are more expensive than HLN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.69
EV/EBITDA 13.89
HLN Per share dataHLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HLN does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of HLN may justify a higher PE ratio.
PEG (NY)3.17
PEG (5Y)1.14
EPS Next 2Y8.72%
EPS Next 3Y9.09%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. HLN Dividend Analysis

5.1 Amount

  • HLN has a Yearly Dividend Yield of 1.95%.
  • Compared to an average industry Dividend Yield of 0.42, HLN pays a better dividend. On top of this HLN pays more dividend than 93.26% of the companies listed in the same industry.
  • HLN's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.95%

5.2 History

  • HLN has paid a dividend for at least 10 years, which is a reliable track record.
  • HLN has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
HLN Yearly Dividends per shareHLN Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.05 0.1 0.15 0.2

5.3 Sustainability

  • HLN pays out 36.71% of its income as dividend. This is a sustainable payout ratio.
DP36.71%
EPS Next 2Y8.72%
EPS Next 3Y9.09%
HLN Yearly Income VS Free CF VS DividendHLN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
HLN Dividend Payout.HLN Dividend Payout, showing the Payout Ratio.HLN Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

HLN Fundamentals: All Metrics, Ratios and Statistics

HALEON PLC-ADR

NYSE:HLN (4/10/2026, 9:28:59 PM)

After market: 9.84 0 (0%)

9.84

-0.17 (-1.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-25
Earnings (Next)04-29
Inst Owners60.66%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap43.87B
Revenue(TTM)11.23B
Net Income(TTM)1.67B
Analysts80
Price Target12.12 (23.17%)
Short Float %0.37%
Short Ratio1.92
Dividend
Industry RankSector Rank
Dividend Yield 1.95%
Yearly Dividend0.18
Dividend Growth(5Y)N/A
DP36.71%
Div Incr Years2
Div Non Decr Years2
Ex-Date04-10
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.73%
Min Revenue beat(2)-3.78%
Max Revenue beat(2)-1.69%
Revenue beat(4)0
Avg Revenue beat(4)-3.44%
Min Revenue beat(4)-4.82%
Max Revenue beat(4)-1.69%
Revenue beat(8)0
Avg Revenue beat(8)-3.28%
Revenue beat(12)1
Avg Revenue beat(12)-2.85%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.72%
PT rev (3m)5.85%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.55%
EPS NY rev (3m)-0.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)-1.33%
Valuation
Industry RankSector Rank
PE 20.08
Fwd PE 17.16
P/S 2.96
P/FCF 14.69
P/OCF 12.39
P/B 1.99
P/tB N/A
EV/EBITDA 13.89
EPS(TTM)0.49
EY4.98%
EPS(NY)0.57
Fwd EY5.83%
FCF(TTM)0.67
FCFY6.81%
OCF(TTM)0.79
OCFY8.07%
SpS3.33
BVpS4.95
TBVpS-2.77
PEG (NY)3.17
PEG (5Y)1.14
Graham Number7.39
Profitability
Industry RankSector Rank
ROA 5.11%
ROE 10.15%
ROCE 9.07%
ROIC 7.04%
ROICexc 7.4%
ROICexgc 256.74%
OM 22.78%
PM (TTM) 15.11%
GM 65.01%
FCFM 20.14%
ROA(3y)4.13%
ROA(5y)3.89%
ROE(3y)8.46%
ROE(5y)7.43%
ROIC(3y)6.87%
ROIC(5y)6.44%
ROICexc(3y)7.38%
ROICexc(5y)6.79%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.85%
ROCE(5y)8.36%
ROICexgc growth 3Y31.03%
ROICexgc growth 5Y32.63%
ROICexc growth 3Y5.68%
ROICexc growth 5Y5.43%
OM growth 3Y0.53%
OM growth 5Y0.46%
PM growth 3Y15.68%
PM growth 5Y5.48%
GM growth 3Y1.63%
GM growth 5Y1.07%
F-Score8
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.87
Debt/EBITDA 2.71
Cap/Depr 114.72%
Cap/Sales 3.74%
Interest Coverage 7.04
Cash Conversion 91.68%
Profit Quality 133.23%
Current Ratio 0.92
Quick Ratio 0.71
Altman-Z 2.49
F-Score8
WACC8.48%
ROIC/WACC0.83
Cap/Depr(3y)107.2%
Cap/Depr(5y)109.42%
Cap/Sales(3y)3.18%
Cap/Sales(5y)3.14%
Profit Quality(3y)146.3%
Profit Quality(5y)135.74%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%280.16%
EPS Next Y6.33%
EPS Next 2Y8.72%
EPS Next 3Y9.09%
EPS Next 5Y7.38%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-0.29%
Revenue Next Year-1.37%
Revenue Next 2Y0.95%
Revenue Next 3Y2.1%
Revenue Next 5Y3.26%
EBIT growth 1Y-1.26%
EBIT growth 3Y1.06%
EBIT growth 5Y2.67%
EBIT Next Year21.48%
EBIT Next 3Y11.4%
EBIT Next 5Y9.2%
FCF growth 1Y12%
FCF growth 3Y8.58%
FCF growth 5Y15.32%
OCF growth 1Y14.47%
OCF growth 3Y8.49%
OCF growth 5Y13.36%

HALEON PLC-ADR / HLN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HALEON PLC-ADR?

ChartMill assigns a fundamental rating of 6 / 10 to HLN.


What is the valuation status of HALEON PLC-ADR (HLN) stock?

ChartMill assigns a valuation rating of 6 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.


Can you provide the profitability details for HALEON PLC-ADR?

HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.


What is the financial health of HALEON PLC-ADR (HLN) stock?

The financial health rating of HALEON PLC-ADR (HLN) is 5 / 10.


Can you provide the dividend sustainability for HLN stock?

The dividend rating of HALEON PLC-ADR (HLN) is 5 / 10 and the dividend payout ratio is 36.71%.